Gradient Investments LLC Exact Sciences Corp Transaction History
Gradient Investments LLC
- $3.51 Billion
- Q2 2024
A detailed history of Gradient Investments LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Gradient Investments LLC holds 64 shares of EXAS stock, worth $4,354. This represents 0.0% of its overall portfolio holdings.
Number of Shares
64
Previous 16
300.0%
Holding current value
$4,354
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding EXAS
# of Institutions
610Shares Held
166MCall Options Held
1.93MPut Options Held
1.23M-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.24 Billion0.02% of portfolio
-
Capital World Investors Los Angeles, CA16.5MShares$1.12 Billion0.12% of portfolio
-
Wellington Management Group LLP Boston, MA14.8MShares$1.01 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$821 Million0.01% of portfolio
-
State Street Corp Boston, MA8.21MShares$559 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $12B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...